|
TMEM126B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.09300000000501E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.544900E-03 |
| Normal-vs-Stage2 |
6.168600E-04 |
| Normal-vs-Stage3 |
4.587900E-04 |
| Normal-vs-Stage4 |
3.75140000000718E-05 |
| Stage1-vs-Stage2 |
1.303010E-01 |
| Stage1-vs-Stage3 |
4.240200E-01 |
| Stage1-vs-Stage4 |
1.288810E-01 |
| Stage2-vs-Stage3 |
3.259800E-01 |
| Stage2-vs-Stage4 |
7.592600E-01 |
| Stage3-vs-Stage4 |
4.008000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.64439999999333E-05 |
| Normal-vs-AfricanAmerican |
1.500230E-03 |
| Normal-vs-Asian |
3.791200E-01 |
| Caucasian-vs-AfricanAmerican |
5.478800E-01 |
| Caucasian-vs-Asian |
7.964400E-03 |
| AfricanAmerican-vs-Asian |
4.088000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.31119999999963E-05 |
| Normal-vs-Female |
1.554930E-04 |
| Male-vs-Female |
2.643400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.518300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.029320E-04 |
| Normal-vs-Age(61-80Yrs) |
2.01579999999923E-05 |
| Normal-vs-Age(81-100Yrs) |
4.658900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.079600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.540000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.607400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.417800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.293000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.736600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.376300E-02 |
| Classical-VS-Follicular |
5.662000E-01 |
| Classical-VS-Other |
3.504400E-01 |
| Classical-VS-Normal |
1.841640E-04 |
| Tall-VS-Follicular |
6.440500E-02 |
| Tall-VS-Other |
8.708200E-01 |
| Tall-VS-Normal |
4.749200E-01 |
| Follicular-VS-Other |
1.381150E-01 |
| Follicular-VS-Normal |
7.359500E-04 |
| Other-VS-Normal |
5.040800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.90899999999284E-05 |
| Normal-vs-N1 |
2.550400E-02 |
| N0-vs-N1 |
2.990200E-01 |
|
|
